Innovations for Substance Use Disorders

Visit our exhibit table and grab some of our swag at @apadivision50 Annual Meeting #CPA2025

Check out our newest webinar: i4sud.com/breaking-throu… Come learn more about the importance of interviews in SUD product development and how our program can help you through the process!

Juan Fernandez, founder of SmartTIVA, Inc., is working on opioid-free anesthesia (OFA), combining AI and real-time patient monitoring to deliver precise, personalized anesthesia without opioids. Welcome to #I4SUD2024, Juan! #OpioidFree #AnesthesiaInnovation #OUD

As a postdoc fellow at @JeffersonUniv, Dr. Shane´J. Gill is working on multilingual software designed for institutions and patients, which will function as an interface for diagnosing and treating substance use disorders. Welcome to #I4SUD2024, Dr. Gill! #DigitalHealth #SUDs

Meet @wkepner and Dr. Junghwan Park from @StanfordMed. They are working on an app to support individuals with SUD by addressing loneliness and social isolation, both significant risk factors for the onset and recurrence of SUDs. Welcome to #I4SUD2024! #SUDRecovery #HealthTech

Assistant Professor of Medicine at @CUAnschutz, @JarrattPytell is working on an AI solution that delivers tailored, "just-in-time" interventions to empower PCPs and patients and improve OUD treatment. Welcome to #I4SUD2024! #OpioidCrisis #PrimaryCare #HealthTech

Meet @ericashrp, a research investigator at @NUNM_EDU. Dr. Sharpe is working on a personalized app that tracks substance use, monitors health outcomes, and offers therapeutic interventions to help users in their recovery. Welcome to #I4SUD2024! #HealthTech #AddictionRecovery

Darian Myers and Hasika Suresh, @TuftsUniversity grad students, are developing an innovative transdermal delivery system for naltrexone that bypasses the digestive system, allowing for sustained, controlled release into the bloodstream. Welcome to #I4SUD2024! #OUD #innovation

Meet @docdiji, an addiction medicine specialist who aims to fill critical gaps In SUD care and treatment by developing robust guidelines that inform care and secure adequate reimbursement. Welcome to the 2024 Cohort, Dr. Vaughan! #SubstanceUseDisorder #AddictionTreatment

John Fitzgerald, PhD is a medical science liaison at @Alkermes. John is working on bridging the Addiction Treatment Gap with a web-based, mobile-friendly platform to help users address substance and behavioral addictions and co-occurring disorders. Welcome to I4SUD 2024!

Dr. Meghan Deshais is an Assistant Professor at @RutgersGSAPP. She is tackling Stimulant-Use Disorder (StUD) with a digital therapeutic to incentivize stimulant abstinence and engagement in healthy activities like exercise. Welcome to the 2024 cohort, Dr. Deshais! #StUD

Ian Martin is a @YaleSPH student and a Business Systems Analyst at @TWCRecoveryLife. Ian is working on a chatbot-driven system that delivers motivational interviewing and integrated case management to support individuals in recovery. Welcome to our 2024 Cohort! #SUDRecovery

Dr. Aldwin Anterola is an Associate Professor at @SIUC and part of our 2024 cohort! Dr. Anterola is investigating CBD, a non-euphoriant compound from cannabis, as a promising alternative to opioid replacement therapy. #OpioidCrisis #CBDResearch #AddictionTreatment

Meet @BizzieGold and Kira Krier, part of I4SUD 2024! They are working on Break Method, a data-driven treatment program that targets underlying issues related to substance use disorders, such as emotional addiction patterns, anxiety, and depression. #AddictionRecovery Welcome!

Meet @violet_kimble, a graduate student at @Yale and part of our 2024 cohort. Violet's app aims to tackle the challenges of substance use disorders by offering personalized support, evidence-based interventions, and a supportive community. #DigitalHealth #RecoverySupport

Dr. Nabil Adam is a Professor Emeritus at @RutgersU, and is identifying and validating FDA-approved drugs for repurposing for opioid disorder treatment. This innovative work aims to provide evidence-supported treatment recommendations and pave the way for new clinical trials.

Exciting news from our co-director!

@KevinBraunsch is a postdoctoral researcher at @IcahnMountSinai and part of our 2024 I4SUD cohort! He is developing novel therapeutics to limit nicotine intake to improve the quality of life for millions struggling to quit smoking. #NicotineAddiction #SmokingCessation

Meet @SalahuddinMoh19, an Assistant Professor of Pharmacology at @NotreDameofMD and part of our 2024 cohort! He is working on a wearable sensor that prioritizes the substance causing the most harm in a person who uses multiple substances. #PolysubstanceUse #HealthTech

Dr. Mike Anastario is a Sociologist and Assistant Professor at @NAU and part of our 2024 cohort. Dr. Anastario's research is focused on harm-reduction tools for those who inject methamphetamine. #HarmReduction #PublicHealth #Innovation